MEMANTINA TEVA 5mg 5mg/dose oral solution
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Find medicines for human use by name or active substance.
Browse by initial
341–360 of 1,296 medicines
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: memantine
N06DX01 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Indicated for: Alzheimer's disease; dementia
Active substance: piracetam
Indicated for: cognitive disorders; cerebral circulatory disorders
Active substance: piracetam
Indicated for: cognitive disorders; cerebral circulatory disorders
Active substance: gadobutrol
V08CA09 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: gadobutrol
V08CA09 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
Indicated for: diagnostic imaging contrast enhancement
Active substance: empagliflozin + metformin
Indicated for: type 2 diabetes mellitus
Active substance: empagliflozin + metformin
Indicated for: type 2 diabetes mellitus
Active substance: empagliflozin + metformin
Indicated for: type 2 diabetes mellitus
Active substance: empagliflozin + metformin
Indicated for: type 2 diabetes mellitus
Active substance: meningococcal vaccine
J07AH07 Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines
Indicated for: prevention of meningococcal disease
Active substance: menotropins
G03GA02 Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants
Indicated for: infertility
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.